Profiling solute carrier transporters in the human blood-brain barrier

Clinical Pharmacology and Therapeutics

Volumn 94, Issue 6, 2013, Pages 636-639

  Geier, E G ^a   Chen, E C ^a   Webb, A ^b   Papp, A C ^b   Yee, S W ^a   Sadee, W ^b,c   Giacomini, K M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER C1; ABC TRANSPORTER C3; ABC TRANSPORTER C4; ABC TRANSPORTER C5; ABC TRANSPORTER C6; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; ORGANIC ANION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 3; PEPTIDE TRANSPORTER 1; REDUCED FOLATE CARRIER; SLC10A1 PROTEIN; SLC22A5 PROTEIN; SLC22A6 PROTEIN; SLC47A1 PROTEIN; SLC47A2 PROTEIN; SLCO2B1 PROTEIN; SOLUTE CARRIER TRANSPORTER; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOASSAY; KIDNEY; LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

BLOOD-BRAIN BARRIER; BRAIN; CEREBRAL CORTEX; GENE EXPRESSION PROFILING; HUMANS; ION PUMPS; KIDNEY; LIVER; MEMBRANE TRANSPORT PROTEINS; MICROVESSELS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84888001037     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.175     Document Type: Article

References (5)

1. Abbott, N.J., Patabendige, A.A., Dolman, D.E., Yusof, S.R. & Begley, D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13-25 (2010).
2. Uchida, Y. et al. Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J. Neurochem. 117, 333-345 (2011).
3. Kwok, J.C., Warren, P. & Fawcett, J.W. Chondroitin sulfate: a key molecule in the brain matrix. Int. J. Biochem. Cell Biol. 44, 582-586 (2012).
4. Zeng, W.Q. et al. Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. Am. J. Hum. Genet. 77, 16-26 (2005).
5. Morrissey, K.M., Stocker, S.L., Wittwer, M.B., Xu, L. & Giacomini, K.M. Renal transporters in drug development. Annu. Rev. Pharmacol. Toxicol. 53, 503-529 (2013).